Trial NCT04793399

View at ClinicalTrials.gov 
Org. Study IDs: ZEROLMC-01

Last trial update was posted on 2024-03-19

MeSH Interventions

Atezolizumab Bosutinib

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Chronic-Phase

Other Conditions

Chronic Phase-Chronic Myeloid Leukemia

Stopping Reasons

The study has been prematurely terminated due to the onset of 2 dose limiting toxicities in 2 patients.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID